Non-stroke Central Neurologic Manifestations in Antiphospholipid Syndrome.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-016-0568-x
- By:
- Publication type:
- Article
Works matching IS 15233774 AND DT 2016 AND VI 18 AND IP 2
Results: 6
1
2
Current Approaches to the Treatment of Systemic-Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH).
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-015-0560-x
- By:
- Publication type:
- Article
3
Cellular Therapies in Systemic Sclerosis: Recent Progress.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-015-0555-7
- By:
- Publication type:
- Article
4
Current Research in Outcome Measures for Pediatric Rheumatic and Autoinflammatory Diseases.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-015-0558-4
- By:
- Publication type:
- Article
5
Organ Damage and Quality of Life in Antiphospholipid Syndrome.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-015-0556-6
- By:
- Publication type:
- Article
6
Causality of Chlamydiae in Arthritis and Spondyloarthritis: a Plea for Increased Translational Research.
- Published in:
- Current Rheumatology Reports, 2016, v. 18, n. 2, p. 1, doi. 10.1007/s11926-015-0559-3
- By:
- Publication type:
- Article